aTyr Pharma (ATYR) Stock: Buy, Sell, or Hold?
ATYR - aTyr Pharma, Inc. Common Stock
$0.29
-0.01 (-2.35%)
▼
5d:
-5.84%
30d:
-41.74%
90d:
-56.08%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When ATYR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ATYR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ATYR shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ATYR is currently trading at $0.29, which is considered oversold relative to its 30-day fair value range of $0.33 to $0.51.
Technical Outlook: Technically, ATYR is in a downtrend. Immediate support is located at $0.27, while resistance sits at $0.41.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.86 (+894.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ATYR is in a downtrend. Immediate support is located at $0.27, while resistance sits at $0.41.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.86 (+894.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.33 -
$0.51
Company Quality Score
49/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: Trading 894.8% below Wall St target ($2.86)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.33 -
$0.51
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.27
Resistance Level
$0.41
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.61
Wall Street Target
$2.86
(+894.8%)
Share & Embed Analysis
Last updated: October 03, 2026 1:16 PM ET
Data refreshes hourly during market hours. Next update: 2:16 PM
Data refreshes hourly during market hours. Next update: 2:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATYR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 76 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$128 | 56 HOLD |
